CLINICAL_TRIALS
trial_result
· 2025-06-06
Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer [Phase 1]
Summary
A Phase 1 study evaluating the safety and tolerability of JS107 in advanced pancreatic cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 1 | Status: TERMINATED